Context Matters @ContextMatters

Context Matters, a health economics data and technology company, delivering solutions to strategically price drugs for reimbursement and optimal market access. contextmatters.com New York, NY Joined April 2011

Tweets

4K
Followers

626
Following

1K
Likes

589

Context Matters @ContextMatters

6 years ago

Data derived intelligence on Access to #orphandrugs in the UK: A review of @NICEComms decisions. Presented today at #ISPOREurope #RachelJao

0 0 2 0 0

Download Image

Context Matters @ContextMatters

6 years ago

Join us at the @DRGinsights #ISPOREurope2019 booth for some bubbly and sweets this evening! Booth C3-059

0 0 0 0 0

Download Image

Context Matters @ContextMatters

6 years ago

Richard Chapman from ICER discusses some of the challenges with evaluating tumor-agnostic therapies. Thank you to all panelists for a fruitful discussion! #HTAi2019 #HTAi2019Cologne

0 0 1 0 0

Download Image

Context Matters @ContextMatters

6 years ago

Heading to #HTAi2019Cologne - join us for a discussion with an expert panel on unified vs. localized #HTA systems bit.ly/2Wxpo6m

0 1 1 0 0

Download Image

NYC Health Business @NYCHBL

7 years ago

Make sure to download your copy of the NYC Healthcare venture report! #HCVC2019

0 3 4 0 0

Download Image

Context Matters @ContextMatters

7 years ago

Great panel tonight for @NYCHBL Where Will the Money Flow in 2019 #HCVC2019

0 1 4 0 0

Download Image

Context Matters @ContextMatters

7 years ago

#startups not seeking input from those they intend to serve is like ignoring #patientvoice in #ClinicalTrials @DataHippie #Data4GoodNY

1 0 0 0 0

Context Matters @ContextMatters

7 years ago

Is the healthcare system late to the table on #SDOH @DrAlethaMaybank #Data4GoodNY

1 1 2 0 0

Context Matters @ContextMatters

7 years ago

If we don't engage the private sector in this discussion...how can we move the needle @DataHippie #Data4GoodNY

0 1 3 0 0

Context Matters @ContextMatters

7 years ago

Community health profiles are powerful tools to improve health and support grant awards @DrAlethaMaybank #Data4GoodNY

0 3 4 0 0

Context Matters @ContextMatters

7 years ago

In the holiday spirit, @NYCHBL panel discussion Using Data for Good is off to a running start!

0 1 3 0 0

Download Image

Context Matters @ContextMatters

7 years ago

Final #ISPORBarcelona workshop had some great audience participation from across the industry and gave us some great ideas on how to increase patient access to #biosimilars in the off-patent biological market.

0 1 1 0 0

Download Image

Context Matters @ContextMatters

7 years ago

Third and final plenary of a fantastic #ISPORBarcelona: the need to control spending in healthcare is clear, but the way to do it is less so. Will expenditure caps be the answer or will this lead to worse health outcomes for patients?

0 2 3 0 0

Download Image

Context Matters @ContextMatters

7 years ago

Come see three of our oncology posters today on the relationship between QALYs and reimbursement decisions in the UK and managed access agreements under the CDF. Then at 12:15, stop by to ask the authors your questions! #ISPORBarcelona

0 0 3 0 0

Download Image

Context Matters @ContextMatters

7 years ago

Ended a great second day at #ISPORBarcelona with a presentation of our poster on the influence of CEESP evaluations on HAS decision making in France.

0 1 1 0 0

Download Image

Context Matters @ContextMatters

7 years ago

Heard three great presentations of cost-effectiveness analyses this afternoon: Pembrolizumab and Midostaurin usage in France and oral cancer screening in Taiwan. Shows the diversity of topics we can apply HEOR methods to! #ISPORBarcelona

0 2 0 0 0

Download Image

Context Matters @ContextMatters

7 years ago

Thought leadership from CM team member Boaz Adler and @Amgen found that time to reimbursement was shorter for biosimilars than the originator product and the rate of positive reimbursement was higher. #ISPORBarcelona

0 2 4 0 0

Download Image

Context Matters @ContextMatters

7 years ago

Big takeaways from the second plenary: Do we need #innovative new treatments? Yes. Do we need new ways to #price innovative treatments? Yes. Do we need new ways to #pay for these treatments? Yes. #ISPORBarcelona

0 7 5 0 1

Download Image

Context Matters @ContextMatters

7 years ago

Last session of the day: Dr. Ana Ferreira Castro (even in absentia) reminds us that we need to get the patient perspective in HTAs in order to make sure that the price we are willing to pay for a drug is the right price. #ISPORBarcelona

0 0 1 0 0

Download Image

Context Matters @ContextMatters

7 years ago

Drs. Chalkidou, Borowitz and Garner discuss the different needs and perspectives of low, middle and high income countries in price setting and determining drug value using HTA value-based pricing vs. WHO fair pricing. Maybe there is no one size fits all approach? #ISPORBarcelona